Relapsed Acute Lymphoblastic Leukemia (ALL) Recruiting Phase 1 Trials for Hydrocortisone (DB00741)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Recruiting	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05292664	Venetoclax Basket Trial for High Risk Hematologic Malignancies	Treatment	Asparaginase Erwinia chrysanthemi (DB08886) Azacitidine (DB00928) Calaspargase pegol (DB14730) Calcium (DB01373) Cortisone (DB14681) Cytarabine (DB00987) Dexamethasone (DB01234) Dexrazoxane (DB00380) Doxorubicin (DB00997) Hydrocortisone (DB00741) Hydrocortisone phosphate (DB14542) Hydrocortisone succinate (DB14545) Leucovorin (DB00650) Methotrexate (DB00563) Venetoclax (DB11581) Vincristine (DB00541)